Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight With Comorbidity”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Large-scale testing (Phase 3)Looking for participantsNCT07743463
What this trial is testing

Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweightChronic Weight Management
Ascletis Pharma (China) Co., Limited 3,003
Testing effectiveness (Phase 2)Study completedNCT06867718
What this trial is testing

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

Who this might be right for
Obesity or Overweight
Regor Pharmaceuticals Inc. 267
Not applicableStudy completedNCT05795166
What this trial is testing

Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland

Who this might be right for
Obesity
Novo Nordisk A/S 1,241
Large-scale testing (Phase 3)Study completedNCT04184622
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Who this might be right for
OverweightObesity
Eli Lilly and Company 2,539
Large-scale testing (Phase 3)Looking for participantsNCT07776509
What this trial is testing

Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity or OverweightWeight-Related ComorbidityWith/Without Diabetes Mellitus, Type 2
AstraZeneca 500
Not applicableNot Yet RecruitingNCT07792226
What this trial is testing

ENLIGHT Trial: ESG With Fundal Mucosal Ablation

Who this might be right for
ObesityObesity (Body Mass Index >30 kg/m2)
West Virginia University 62
Large-scale testing (Phase 3)WithdrawnNCT05209984
What this trial is testing

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

Who this might be right for
OverweightObesity
Eurofarma Laboratorios S.A.
Early research (Phase 1)Study completedNCT04167553
What this trial is testing

Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities

Who this might be right for
Obese With ComorbiditiesOverweight With ComorbiditiesType2 Diabetes
Hanmi Pharmaceutical Company Limited 52
Not applicableNot Yet RecruitingNCT07492563
What this trial is testing

Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay

Who this might be right for
ObesityType 2 Diabetes MellitusOverweight With Comorbidities
LABORATORIOS INDUFAR 300
Post-approval studies (Phase 4)UnknownNCT05872269
What this trial is testing

Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Who this might be right for
NAFLDObesityType 2 Diabetes+2 more
Zydus Lifesciences Limited 1,500
Large-scale testing (Phase 3)Ended earlyNCT00412698
What this trial is testing

European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia

Who this might be right for
ObesityDyslipidemias
Sanofi 645
Testing effectiveness (Phase 2)Study completedNCT06703021
What this trial is testing

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightChronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 85
Not applicableLooking for participantsNCT07780188
What this trial is testing

Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)

Who this might be right for
PCOS (Polycystic Ovary Syndrome)Obese AdolescentsOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities+5 more
Texas A&M University 36
Testing effectiveness (Phase 2)Study completedNCT06595238
What this trial is testing

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
Obesity or Overweight
AstraZeneca 262
Not applicableStudy completedNCT03233048
What this trial is testing

Intragastric Balloon in Obese Adolescents With Comorbidities

Who this might be right for
Obesity
Imad Absah 5
Large-scale testing (Phase 3)Study completedNCT06584916
What this trial is testing

Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

Who this might be right for
ObesityOverweight
Eli Lilly and Company 376
Large-scale testing (Phase 3)Active Not RecruitingNCT06972459
What this trial is testing

Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Who this might be right for
ObesityOverweight
Eli Lilly and Company 800
Not applicableWithdrawnNCT05209997
What this trial is testing

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

Who this might be right for
OverweightObesity
Eurofarma Laboratorios S.A.
Not applicableNot Yet RecruitingNCT07609160
What this trial is testing

Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals

Who this might be right for
ObesitySarcopeniaOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Acibadem University 108
Testing effectiveness (Phase 2)Study completedNCT06862791
What this trial is testing

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Who this might be right for
Obesity or Overweight
AstraZeneca 377
Next Page